Fibril structure of amyloid-β(1–42) by cryo–electron microscopy

Lothar Gremer,Daniel Schölzel,Carla Schenk,Elke Reinartz,Jörg Labahn,Raimond B G Ravelli,Markus Tusche,Carmen Lopez-Iglesias,Wolfgang Hoyer,Henrike Heise,Dieter Willbold,Gunnar F Schröder,Raimond B. G. Ravelli,Gunnar F. Schröder
DOI: https://doi.org/10.1126/science.aao2825
IF: 56.9
2017-10-06
Science
Abstract:Elucidating pathological fibril structure Amyloid-β (Aβ) is a key pathological contributor to Alzheimer's disease. Gremer et al. used cryoelectron microscopy data to build a high-quality de novo atomic model of Aβ fibrils (see the Perspective by Pospich and Raunser). The complete structure reveals all 42 amino acids (including the entire N terminus) and provides a structural basis for understanding the effect of several disease-causing and disease-preventing mutations. The fibril consists of two intertwined protofilaments with an unexpected dimer interface that is different from those proposed previously. The structure has implications for the mechanism of fibril growth and will be an important stepping stone to rational drug design. Science , this issue p. 116 ; see also p. 45
multidisciplinary sciences
What problem does this paper attempt to address?
Based on the provided information, the main problem that this paper "Fibril structure of amyloid - β(1 - 42) by cryoelectron microscopy" attempts to solve is to determine the fibril structure formed by amyloid - β(1 - 42). Amyloid - β(1 - 42) is a protein fragment closely related to Alzheimer's disease (AD). Understanding the specific structure of this protein is of great significance for revealing its mechanism of action in disease development and developing new treatment methods for Alzheimer's disease. The author used the cryo - electron microscopy (cryo - EM) technique, which is a high - resolution imaging technique capable of observing structural details at the molecular level, thus providing direct visual evidence for the three - dimensional structure of amyloid - β(1 - 42) fibrils. This study not only enhances our understanding of Alzheimer's disease pathology but also provides important structural information for future drug design.